Intuitive Surgical, Inc. $ISRG Shares Acquired by Global Retirement Partners LLC

Global Retirement Partners LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 70.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 23,876 shares of the medical equipment provider’s stock after buying an additional 9,909 shares during the quarter. Global Retirement Partners LLC’s holdings in Intuitive Surgical were worth $13,522,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the stock. Vanguard Group Inc. grew its stake in shares of Intuitive Surgical by 0.8% in the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after buying an additional 263,828 shares in the last quarter. Capital World Investors grew its stake in shares of Intuitive Surgical by 1.5% in the third quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider’s stock valued at $3,456,223,000 after buying an additional 116,034 shares in the last quarter. Fisher Asset Management LLC grew its stake in shares of Intuitive Surgical by 1.1% in the third quarter. Fisher Asset Management LLC now owns 3,889,439 shares of the medical equipment provider’s stock valued at $1,739,475,000 after buying an additional 40,702 shares in the last quarter. Amundi grew its stake in shares of Intuitive Surgical by 29.7% in the third quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock valued at $1,451,362,000 after buying an additional 739,444 shares in the last quarter. Finally, Jennison Associates LLC grew its stake in shares of Intuitive Surgical by 11.1% in the fourth quarter. Jennison Associates LLC now owns 3,209,137 shares of the medical equipment provider’s stock valued at $1,817,527,000 after buying an additional 321,759 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. Piper Sandler lowered their target price on Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Truist Financial lowered their target price on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research note on Wednesday, April 15th. Citigroup upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 target price for the company in a research note on Wednesday, March 11th. The Goldman Sachs Group increased their target price on Intuitive Surgical from $609.00 to $621.00 and gave the company a “buy” rating in a research note on Wednesday, April 22nd. Finally, Jefferies Financial Group reduced their price target on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a report on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $579.33.

Intuitive Surgical Stock Performance

ISRG opened at $449.03 on Thursday. Intuitive Surgical, Inc. has a one year low of $417.74 and a one year high of $603.88. The stock’s fifty day moving average is $460.63 and its 200-day moving average is $511.79. The company has a market capitalization of $159.03 billion, a PE ratio of 54.43, a P/E/G ratio of 3.53 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The company had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The company’s quarterly revenue was up 23.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.81 EPS. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 105 shares of the firm’s stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Amy L. Ladd sold 119 shares of the firm’s stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the sale, the director directly owned 120 shares of the company’s stock, valued at approximately $55,620. This represents a 49.79% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 5,683 shares of company stock worth $2,775,891. 0.60% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.